Stock-Based Compensation - Summary of Changes in SARs Outstanding (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Weighted Average Remaining Contractual Term (Years)
Granted	1 year 7 months 6 days
Stock appreciation rights
SARs
Outstanding, Beginning Balance (in shares)	0.8
Granted (in shares)	0.1
Exercised (in shares)	(0.3)
Outstanding, Ending Balance (in shares)	0.6	0.8
Vested and exercisable, ending balance (in shares)	0.3
Per Share Weighted Average Exercise Price
Outstanding, Beginning Balance (in dollars per share)	$ 168.16
Granted (in dollars per share)	348.47
Exercised (in dollars per share)	129.05
Outstanding, Ending Balance (in dollars per share)	216.40	$ 168.16
Vested and exercisable, ending balance (in Dollars per share)	170.63
Per Share Weighted Average Grant Date Fair Value
Outstanding, Beginning Balance (in dollars per share)	42.99
Granted (in dollars per share)	126.04
Exercised (in Dollars per share)	29.60
Outstanding, Ending Balance (in dollars per share)	62.85	$ 42.99
Vested and exercisable, ending balance (in Dollars per share)	$ 42.88
Weighted Average Remaining Contractual Term (Years)
Weighted average remaining contractual terms	3 years 11 months 1 day	3 years 10 months 20 days
Granted	5 years 9 months 10 days
Weighted average remaining contractual terms vested and exercisable	3 years 3 months
Unvested SARs (in shares)	0.6	0.8
Aggregate intrinsic value of outstanding shares	$ 139.9
Aggregate intrinsic value of shares vested and exercisable	$ 81.3
Stock appreciation rights | Unvested
SARs
Outstanding, Ending Balance (in shares)	0.3
Weighted Average Remaining Contractual Term (Years)
Unvested SARs (in shares)	0.3